APERIGEN

Serial Number 88668197
606

Registration Progress

Application Filed
Oct 24, 2019
Under Examination
Aug 11, 2020
Approved for Publication
Jun 16, 2020
Published for Opposition
Jun 16, 2020
Registered

Trademark Image

APERIGEN

Basic Information

Serial Number
88668197
Filing Date
October 24, 2019
Published for Opposition
June 16, 2020
Abandonment Date
March 20, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 20, 2023
Classes
001 005 010 042
+1 more

Rights Holder

OncoCyte Corporation

03
Address
15 Cushing
Irvine, CA 92618

Ownership History

OncoCyte Corporation

Original Applicant
03
Alameda, CA

OncoCyte Corporation

Owner at Publication
03
Irvine, CA

Legal Representation

Attorney
Christopher D. Olszyk, Jr.

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Mar 20, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 20, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 11, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 9, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 9, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 9, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 3, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 3, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 3, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 12, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 10, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 10, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 10, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 9, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 9, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 11, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 17, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 17, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 16, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 16, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 27, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 13, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 13, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 13, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 12, 2020 ALIE A ASSIGNED TO LIE Loading...
May 6, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 30, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 29, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 30, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 28, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Class 005
Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
Class 010
Liquid and tissue biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting cancer; blood testing apparatus for cancer diagnosis; medical testing devices for tumor diagnosis
Class 042
Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
Class 044
Providing cancer screening services

Additional Information

Translation
The wording "APERIGEN" has no meaning in a foreign language.

Classification

International Classes
001 005 010 042 044